Terms: = Prostate cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Diagnosis
419 results:
1. Is Unilateral Lymphadenectomy an Option in Selected Patients with prostate cancer?
Kassab BN; De Pablos-Rodríguez P; Ferrer ÁG; García AC; Fons AC; Aragón F; Ramón-Borja JC; Ramírez-Backhaus M
Arch Esp Urol; 2024 Mar; 77(2):129-134. PubMed ID: 38583004
[TBL] [Abstract] [Full Text] [Related]
2. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
Habeshian TS; Cannavale KL; Slezak JM; Shu YH; Chien GW; Chen X; Shi F; Siegmund KD; Van Den Eeden SK; Huang J; Chao CR
Epigenetics; 2024 Dec; 19(1):2308920. PubMed ID: 38525786
[TBL] [Abstract] [Full Text] [Related]
3. Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths.
Chang ET; Clarke CA; Colditz GA; Kurian AW; Hubbell E
Cancer Causes Control; 2024 May; 35(5):849-864. PubMed ID: 38238615
[TBL] [Abstract] [Full Text] [Related]
4. Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study.
Gallagher BDT; Chiam K; Bang A; Patel MI; Kench JG; Edwards S; Nair-Shalliker V; Smith DP
Pathology; 2024 Feb; 56(1):39-46. PubMed ID: 38104002
[TBL] [Abstract] [Full Text] [Related]
5. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract] [Full Text] [Related]
6. prostate cancer treatment in Portugal: a nationwide analysis.
Botelho F; Lopes R; Pina F; Silva C; Pacheco-Figueiredo L; Lunet N
Sci Rep; 2023 Nov; 13(1):19362. PubMed ID: 37938598
[TBL] [Abstract] [Full Text] [Related]
7. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract] [Full Text] [Related]
8. cancer incidence in the US military: An updated analysis.
Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
[TBL] [Abstract] [Full Text] [Related]
9. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract] [Full Text] [Related]
10. Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.
Shore R; Zhang J; Ye W; Stattin P; Lindblad M
Cancer Causes Control; 2023 Nov; 34(11):949-961. PubMed ID: 37341814
[TBL] [Abstract] [Full Text] [Related]
11. Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population-based registry data.
Charvat H; Fukui K; Matsuda T; Katanoda K; Ito Y
Int J Cancer; 2023 Sep; 153(6):1162-1171. PubMed ID: 37278616
[TBL] [Abstract] [Full Text] [Related]
12. Neighbourhood social deprivation and risk of prostate cancer.
Salmon C; Quesnel-Vallée A; Barnett TA; Benedetti A; Cloutier MS; Datta GD; Kestens Y; Nicolau B; Parent MÉ
Br J Cancer; 2023 Aug; 129(2):335-345. PubMed ID: 37188877
[TBL] [Abstract] [Full Text] [Related]
13. Focal Therapy for Renal cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape.
Flegar L; Thoduka SG; Mahnken AH; Figiel J; Heers H; Aksoy C; Eisenmenger N; Groeben C; Huber J; Zacharis A
Urol Int; 2023; 107(4):396-405. PubMed ID: 36702105
[TBL] [Abstract] [Full Text] [Related]
14. Exposure to statins post localized prostate cancer diagnosis and risk of metastasis among men who did not receive curative prostate cancer treatment.
Habeshian TS; Shu YH; Cannavale KL; Slezak JM; Chien GW; Vandeneeden SK; Chao CR
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1749. PubMed ID: 36349511
[TBL] [Abstract] [Full Text] [Related]
15. Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study.
Egger S; Smith DP; Patel MI; Kimlin MG; Armstrong BK; Nair-Shalliker V
Br J Cancer; 2023 Jan; 128(1):71-79. PubMed ID: 36319848
[TBL] [Abstract] [Full Text] [Related]
16. Epidemiological Study of prostate cancer in the Province of Salamanca (2006-2015).
Bartolomé Gutiérrez JS; Abad AS; Domínguez FS; Ludeña de la Cruz MD; Hernández JJC
Arch Esp Urol; 2022 Sep; 75(7):630-637. PubMed ID: 36214145
[TBL] [Abstract] [Full Text] [Related]
17. Association of Gonadotropin-Releasing Hormone Agonists for prostate cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes.
Lin E; Garmo H; Van Hemelrijck M; Zethelius B; Stattin P; Hagström E; Adolfsson J; Crawley D
JAMA Netw Open; 2022 Aug; 5(8):e2225600. PubMed ID: 35939302
[TBL] [Abstract] [Full Text] [Related]
18. Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study.
Nair-Shalliker V; Bang A; Egger S; Yu XQ; Chiam K; Steinberg J; Patel MI; Banks E; O'Connell DL; Armstrong BK; Smith DP
Br J Cancer; 2022 Sep; 127(4):735-746. PubMed ID: 35610365
[TBL] [Abstract] [Full Text] [Related]
19. Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019.
Flegar L; Zacharis A; Aksoy C; Heers H; Derigs M; Eisenmenger N; Borkowetz A; Groeben C; Huber J
World J Urol; 2022 Jul; 40(7):1645-1652. PubMed ID: 35562598
[TBL] [Abstract] [Full Text] [Related]
20. Relationships between erectile dysfunction, prostate cancer treatment type and inflatable penile prosthesis implantation.
Shen C; Jain K; Shah T; Schaefer E; Zhou S; Fried D; Helmer DA; Sadeghi-Nejad H
Investig Clin Urol; 2022 May; 63(3):316-324. PubMed ID: 35534219
[TBL] [Abstract] [Full Text] [Related]
[Next]
